cardiac surgery
Conditions
Interventions
the volatile group:received sevoflurane or desflurane during surgery
the TIVA group:received any intravenous agent and no volatile agent during surgery
Sponsors
Department of Anesthesiology, West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. aged older than 18 years; 2. elective cardiac surgery; 3. signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Minimally invasive cardiac surgery (e.g. transthoracic atrial or ventricular septal defect closure, pericardiectomy); 2. emergency surgery; 3. pregnancy; 4. suspected family history of malignant hyperthermia or propofol infusion syndrome; 5. failed to cooperate with follow-up because of disturbance of comprehension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a composite of major complications and death from any cause occurring within the first 30 days; | — |
Secondary
| Measure | Time frame |
|---|---|
| mortality from any cause at 6-month and at one year;quality of life at one year (SF-8);postoperative mechanical ventilation time;the length of stay in intensive care unit;the length of stay in hospital;total hospital cost; | — |
Countries
China
Contacts
Public ContactJin Liu
Department of Anesthesiology, West China Hospital of Sichuan University
Outcome results
None listed